Figure 1: Funding for SRH conditions in 2023, in USD millions Beyond size, the maturity of the R&D landscape for these conditions is also reflected in where investment is focused
The system provides modest support for existing healthy behaviors but cannot overcome terrible diet and zero exercise
GLP-1 agonists can be valuable for selected patients, particularly those with obesity and metabolic comorbidities, but long-term PCOS care should remain holistic combining metabolic management with mental health support, lifestyle sustainability, reproductive health, and patient education
doi: 10.3390/ijms22020544 40 LiuSWuZChenXChenZShenYQadirSet al
While much is known about free radicals and their general effects, detailed mechanistic studies are needed to understand how specific radicals contribute to various diseases at the molecular level